|
UBE2E3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.152800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.588200E-01 |
| Normal-vs-Stage2 |
1.184440E-01 |
| Normal-vs-Stage3 |
9.983800E-01 |
| Normal-vs-Stage4 |
4.262600E-01 |
| Stage1-vs-Stage2 |
3.170600E-01 |
| Stage1-vs-Stage3 |
7.825800E-01 |
| Stage1-vs-Stage4 |
5.605800E-01 |
| Stage2-vs-Stage3 |
3.524000E-01 |
| Stage2-vs-Stage4 |
8.859200E-01 |
| Stage3-vs-Stage4 |
5.986200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.250600E-01 |
| Normal-vs-AfricanAmerican |
8.916200E-01 |
| Normal-vs-Asian |
5.864100E-02 |
| Caucasian-vs-AfricanAmerican |
7.207200E-01 |
| Caucasian-vs-Asian |
2.476200E-01 |
| AfricanAmerican-vs-Asian |
9.391900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.571630E-01 |
| Normal-vs-Female |
3.085400E-01 |
| Male-vs-Female |
2.426200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.143200E-01 |
| Normal-vs-Extreme_Weight |
3.156200E-01 |
| Normal-vs-Obese |
4.557400E-01 |
| Normal-vs-Extreme_Obese |
2.557200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.463800E-01 |
| Normal_Weight-vs-Obese |
7.770400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.793200E-01 |
| Extreme_Weight-vs-Obese |
8.019200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.415000E-01 |
| Obese-vs-Extreme_Obese |
6.140600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.595700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.422600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.118200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.384800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.235620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.744000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.117800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.129400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.677200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.255400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.192200E-01 |
| Normal-VS-Type2 PRCC |
1.011170E-01 |
| Normal-VS-KIRP CIMP |
2.48819999999483E-05 |
| Normal-VS-Unclassified PRCC |
1.960850E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.200340E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.818190E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.439800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.738000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.165600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.924300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.444400E-02 |
| Normal-vs-N1 |
7.485000E-01 |
| Normal-vs-N2 |
5.677700E-02 |
| N0-vs-N1 |
4.526800E-01 |
| N0-vs-N2 |
9.958100E-03 |
| N1-vs-N2 |
3.314000E-01 |
|
|
